I

Integer Holdings Corporation

Medical device CDMO for cardiac devices

Operations Manager

Full-TimeUpdated on 10/23/2026
$108.1k - $158.5k+ Cash-based incentive program
Mid, Senior
Bachelor's, Master's
Bedford, MA, USA
In Person
Manufacturing & Production Operations

About the job

Requirements
  • An accomplished track record in production environments with ownership of results, particularly the listed key performance indicators, and at least three years of previous leadership experience.
  • Firsthand experience implementing or sustaining Manufacturing Excellence and Lean practices.
  • Demonstrated strategic and direct people-management experience in fast-paced, complex manufacturing environments producing both made-to-stock and made-to-order products.
  • Evidence of learning, retaining, and applying knowledge, with technical learning and experience relevant to the role’s expectations.
  • A Bachelor’s degree in Operations Management, Engineering, or a similar discipline, or a Master’s degree in business or a technical discipline, is preferred but not required.
  • Strong problem-solving skills and critical-thinking and decision-making ability.
  • Financial acumen, including the ability to navigate a typical profit and loss statement, explain how role results affect profitability, and experience managing inventories.
  • Leadership skills, including awareness of emotional intelligence and the ability to apply beliefs supporting strengths as a people developer.
  • A well-developed ability to plan, execute, and deliver projects on time and within budget.
Responsibilities
  • Provide leadership for multiple Production Supervisors and individual performers and oversee all aspects of manufacturing operations for assigned product lines and processes at a manufacturing site.
  • Sustain and optimize production, ensure built-in product quality, complete continuous-improvement projects, manage interfaces with support teams, and receive new products and technologies released onto product lines.
  • Own production activities for defined product lines at a manufacturing site and deliver the established key performance goals and targets.
  • Represent the Operations Team and contribute to annual Operations goals and objectives; represent the team to the Site Leadership Team as appropriate.
  • Lead direct reports, including Production Supervisors and individual performers.
  • Follow company values, policies, procedures, and work instructions, and ensure compliance with the Quality Management System and Environmental, Health, Safety, and Security protocols.
  • Provide input to and lead execution of manufacturing imperatives in the site Hoshin Plan; develop and execute sustained continuous-improvement processes.
  • Define direct reports’ goals and objectives and supporting key performance indicators covering safety, quality, delivery, inventory, and productivity.
  • Develop individual growth and development plans and organizational succession plans.
  • Observe operations at the Gemba, ask questions, and listen actively; communicate at production boards, project update meetings, KPI reviews, and Town Hall meetings; engage associates across functions and levels.
  • Hold regular one-on-one meetings with direct reports to monitor performance and progress on individual development plans.
  • Interact with internal and external customers, support customer business reviews, and participate in customer or other-party site visits and audits as needed.
  • Align strategies, tactics, and actions with Operations peers to achieve operational objectives.
  • Collaborate with Research and Development and Product Development to prioritize Operations resources and support for new product launches.
  • Embed quality in Operations by ensuring adherence to the Quality Management System, facilitating corrective and preventive actions, and contributing to quality key performance indicators and the journey to 5 Sigma.
  • Perform other duties as needed and directed.
  • Champion deployment of systems and tools to optimize production activities across the site.
  • Apply Manufacturing Excellence through the Integer Production System focus areas: strategy alignment using Site Hoshin Plans, Sales, Inventory, and Operations Planning meetings, and value-stream-map updates; sustained change through production monitoring, improvement activities, and Leader Standard Work; standardization through workplace organization, visual controls (5S), Manufacturing Standard Work, and training and certification programs; associate engagement through standardized problem-solving methods, behavior-based safety programs, and improvement idea and suggestion systems; and systems and process optimization through built-in quality, optimized scheduling and material-system designs, work-cell design, and total productive maintenance.
  • Participate in developing and vetting production plans with Production, Planning, Continuous Improvement, Customer Service, Quality, and Materials representatives to meet customer requirements.
  • Monitor actual daily and longer-term performance against the production plan and drive actions to address off-standard performance.
  • Ensure change management requirements and customer notifications are followed.
  • Deliver results measured by safety observations and improvement suggestions; associate engagement, voluntary turnover, and time to fill positions; customer complaints, nonconformance and corrective-action cycle times, and supplier performance; delivery and schedule/takt attainment; inventory days on hand and turns; first-pass yield, labor efficiency, overall equipment effectiveness, throughput, parts per person-hour, and unscheduled downtime; cumulative cost savings; and production-cost-center budget adherence and overtime usage.
Desired Qualifications
  • Willingness to consider relocation opportunities and rotational assignments for potential future career growth and progression within Integer.
  • A calm demeanor in a high-energy, constantly changing production environment.

About the company

I

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $464.1 million, beating estimates despite weak medtech demand.
  • Integer expects demand recovery after New Ross's July 27-August 10, 2026 shutdown.
  • KKR plans new capacity, technology, and employee ownership after closing by year-end 2026.

What critics are saying

  • Integer withdrew 2026 guidance on August 3, 2026, after KKR announced the buyout.
  • Schall, Brown & Schwartz opened an August 23, 2026 fiduciary-duty investigation.
  • Regulatory or stockholder rejection kills the KKR deal and leaves Integer's weak standalone outlook exposed.

What makes Integer Holdings Corporation unique

  • Integer's R&D Velocity integrates design, prototyping, and manufacturing for complex medtech programs.
  • Its 33-facility global network spans electrophysiology, neuromodulation, and structural heart.
  • KKR's August 3, 2026, $5.7 billion bid validates Integer's scale and customer lock-in.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Adoption Assistance
  • Parental Leave
  • 401(k) Company Match
  • 401(k) Retirement Plan
  • Paid Vacation
  • Paid Holidays

Growth & Insights and Company News

6 month growth

1%

1 year growth

0%

2 year growth

0%
Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.